Egyptian Pharmaceutical Market Research

































2026-08-02
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI China 2023 | At the Heart of Pharma
-
A Guide Into What the Pharmaceutical Use of Hexamine Is
-
In line with the 8201, Hengrui Pharmaceutical plans the HER2 ADC in this way
-
$50 billion in products were 'returned' to rationalize those blockbuster BD deals
-
Tronsound long-acting IL-36R antibody obtained FDA clinical IND
-
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
-
The FDA accepted Zuranolone's NDA application and granted it priority review rights for the treatment of MDD and PDD
-
Asia Hong Pharma announced that it has co-developed an innovative tumor therapy based on AI+RNA technology route with ReviR
-
Ribo Biologics announced that the world's first FIH application for a siRNA drug targeting FXI has been successfully approved by HREC in Australia
-
Focusing on hearing and balanced medicine, why did Shurui Medical break into the 10 billion market of digital therapeutics?
Recommend Reading
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
DKSH Upgrades its Malaysia Innovation Center to Strengthen Technical Service Capabilities for the Southeast Asian Market
-
Axplora Expands Indian Market: €6.5 Million to Expand API Manufacturing in Vizag
-
Supplement Recall Puts Nutrition Ingredient Safety Back Under Pressure
-
API Supplier Audits Move to the Center of Pharma Supply Resilience
-
Supply-Demand Game, Dichloromethane Under Pressure and Declining
-
Benzalkonium Chloride: Essential Uses, Safety Tips & Cleaning Guide
-
August Hydrofluoric Acid Market Prices Continue to Show Weak Performance in China
-
This week, the market price of epichlorohydrin in China remains firm at a high level
-
Bullish Support Propels Adipic Acid Prices Higher in China